Global Amlodipine Market Report, History and Forecast 2016-2027, Breakdown Data by Manufacturers, Key Regions, Types and Application

Amlodipine, a calcium antagonist, can be used to treat various types of hypertension (alone or in combination with other drugs) and angina pectoris, especially spontaneous angina pectoris (alone or in combination with other drugs).This product has certain protective effect on kidney.The preparation includes amlodipine benzene sulfonate tablets, amlodipine mesylate tablets, levoamlodipine maleic acid tablets, etc.

Market Analysis and Insights: Global Amlodipine Market
In 2020, the global Amlodipine market size was US$ XX million and it is expected to reach US$ XX million by the end of 2027, with a CAGR of XX% between 2021 and 2027
Global Amlodipine Scope and Market Size
The global Amlodipine market is segmented by region (country), company, by Type, and by Application. Players, stakeholders, and other participants in the global Amlodipine market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), byType, and by Application for the period 2016-2027.


Segment by Type
by Product
Amlodipine Benzene Sulfonate Tablet
Amlodipine Mesylate Tablet
Levoamlodipine Maleic Acid Tablet
by Form
Tablets
Capsule


Segment by Application
High Blood Pressure
Angina Pectoris
Other


By Company
Novartis
Pfizer
Lek
TEVA
Macleods Pharmaceuticals
Caraco Pharmaceutical
Sanis Health
Jamp Pharma
Accel Pharma
Jubilant Generics
Angita Pharma
Florida DOH Central Pharmacy
Shanghai Disainuo Biopharmaceutical
Northeast Pharmaceutical Group Shenyang No. 1 Pharmaceutical
Beijing Wansheng Pharmaceutical
Beijing Honglin Pharmaceutical
Beijing Maidihai Pharmaceutical
China Resources Saike Pharmaceutical
Beijing Jiulong Pharmaceutical
Tiannian Pharmaceutical
Chengdu Diao Pharmaceutical Group
Yangtze Pharmaceutical
Kunming Sino Pharmaceutical
Wuhan Dongxin Pharmaceutical Technology
Jiangsu Wangao Pharmaceutical
Jiangsu Lianhuan Pharmaceutical
Jiangsu Huanghe Pharmaceutical
Zhejiang Jingxin Pharmaceutical
Zhejiang Jianfeng Pharmaceutical
Hunan Qianjinxieli Pharmaceutical


By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Colombia
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE